AAAAAA

   
Results: 1-16 |
Results: 16
LIMITED TUMOR INVOLVEMENT FOUND AT MULTIPLE ENDOCRINE NEOPLASIA TYPE-I PANCREATIC EXPLORATION - CAN IT BE PREDICTED BY PREOPERATIVE TUMOR-LOCALIZATION
Authors: SKOGSEID B OBERG K AKERSTROM G ERIKSSON B WESTLIN JE JANSON ET EKLOF H ELVIN A JUHLIN C RASTAD J
Citation: B. Skogseid et al., LIMITED TUMOR INVOLVEMENT FOUND AT MULTIPLE ENDOCRINE NEOPLASIA TYPE-I PANCREATIC EXPLORATION - CAN IT BE PREDICTED BY PREOPERATIVE TUMOR-LOCALIZATION, World journal of surgery, 22(7), 1998, pp. 673-678
DETERMINATION OF SOMATOSTATIN RECEPTOR SUBTYPE 2 IN CARCINOID-TUMORS BY IMMUNOHISTOCHEMICAL INVESTIGATION WITH SOMATOSTATIN RECEPTOR SUBTYPE-2 ANTIBODIES
Authors: JANSON ET STRIDSBERG M GOBL A WESTLIN JE OBERG K
Citation: Et. Janson et al., DETERMINATION OF SOMATOSTATIN RECEPTOR SUBTYPE 2 IN CARCINOID-TUMORS BY IMMUNOHISTOCHEMICAL INVESTIGATION WITH SOMATOSTATIN RECEPTOR SUBTYPE-2 ANTIBODIES, Cancer research, 58(11), 1998, pp. 2375-2378
CARCINOID-TUMORS - ANALYSIS OF PROGNOSTIC FACTORS AND SURVIVAL IN 301PATIENTS FROM A REFERRAL CENTER
Authors: JANSON ET HOLMBERG L STRIDSBERG M ERIKSSON B THEODORSSON E WILANDER E OBERG K
Citation: Et. Janson et al., CARCINOID-TUMORS - ANALYSIS OF PROGNOSTIC FACTORS AND SURVIVAL IN 301PATIENTS FROM A REFERRAL CENTER, Annals of oncology, 8(7), 1997, pp. 685-690
INDUCTION OF APOPTOSIS IN NEUROENDOCRINE TUMORS OF THE DIGESTIVE-SYSTEM DURING TREATMENT WITH SOMATOSTATIN ANALOGS
Authors: IMAM H ERIKSSON B LUKINIUS A JANSON ET LINDGREN PG WILANDER E OBERG K
Citation: H. Imam et al., INDUCTION OF APOPTOSIS IN NEUROENDOCRINE TUMORS OF THE DIGESTIVE-SYSTEM DURING TREATMENT WITH SOMATOSTATIN ANALOGS, Acta oncologica, 36(6), 1997, pp. 607-614
NEUROENDOCRINE GASTROENTEROPANCREATIC TUMORS ARE THEY HEREDITARY
Authors: SCHERUBL H BREDEEK U JANSON ET RIECKEN EO WIEDENMANN B SKOGSEID B QUABBE HJ OBERG K
Citation: H. Scherubl et al., NEUROENDOCRINE GASTROENTEROPANCREATIC TUMORS ARE THEY HEREDITARY, Gastroenterology, 112(4), 1997, pp. 651-651
THE USE OF NEW SOMATOSTATIN ANALOGS, LANREOTIDE AND OCTASTATIN, IN NEUROENDOCRINE GASTROINTESTINAL TUMORS
Authors: ERIKSSON B JANSON ET BAX NDS MIGNON M MORANT R OPOLON P ROUGIER P OBERG KE
Citation: B. Eriksson et al., THE USE OF NEW SOMATOSTATIN ANALOGS, LANREOTIDE AND OCTASTATIN, IN NEUROENDOCRINE GASTROINTESTINAL TUMORS, Digestion, 57, 1996, pp. 77-80
A COMPARISON BETWEEN THE EFFICACY OF SOMATOSTATIN RECEPTOR SCINTIGRAPHY AND THAT OF IN-SITU HYBRIDIZATION FOR SOMATOSTATIN RECEPTOR SUBTYPE2 MESSENGER-RNA TO PREDICT THERAPEUTIC OUTCOME IN CARCINOID PATIENTS
Authors: JANSON ET GOBL A KALKNER KM OBERG K
Citation: Et. Janson et al., A COMPARISON BETWEEN THE EFFICACY OF SOMATOSTATIN RECEPTOR SCINTIGRAPHY AND THAT OF IN-SITU HYBRIDIZATION FOR SOMATOSTATIN RECEPTOR SUBTYPE2 MESSENGER-RNA TO PREDICT THERAPEUTIC OUTCOME IN CARCINOID PATIENTS, Cancer research, 56(11), 1996, pp. 2561-2565
INDUCTION OF MXA MESSENGER-RNA IN PATIENTS WITH NEUROENDOCRINE TUMORSAFTER INTERFERON TREATMENT - LACK OF CORRELATION WITH ANTITUMOR RESPONSE
Authors: IMAM H JANSON ET GOBL A ALM G OBERG K
Citation: H. Imam et al., INDUCTION OF MXA MESSENGER-RNA IN PATIENTS WITH NEUROENDOCRINE TUMORSAFTER INTERFERON TREATMENT - LACK OF CORRELATION WITH ANTITUMOR RESPONSE, Anticancer research, 15(5), 1995, pp. 2191-2195
SOMATOSTATIN RECEPTOR SCINTIGRAPHY IN PATIENTS WITH CARCINOID-TUMORS - COMPARISON BETWEEN RADIOLIGAND UPTAKE AND TUMOR-MARKERS
Authors: KALKNER KM JANSON ET NILSSON S CARLSSON S OBERG K WESTLIN JE
Citation: Km. Kalkner et al., SOMATOSTATIN RECEPTOR SCINTIGRAPHY IN PATIENTS WITH CARCINOID-TUMORS - COMPARISON BETWEEN RADIOLIGAND UPTAKE AND TUMOR-MARKERS, Cancer research, 55(23), 1995, pp. 5801-5804
TROPISETRON (NAVOBAN) IN THE PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING - THE NORDIC EXPERIENCE
Authors: SORBE B ANDERSSON H SCHMIDT M SODERBERG M HOGBERG T WERNSTEDT L JANSON ET EHRNSTROM B KJAER M HAVSTEEN H OVERGAARD M SANDBERG E FLANDER M HEIKKINEN M NIKKANEN V
Citation: B. Sorbe et al., TROPISETRON (NAVOBAN) IN THE PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING - THE NORDIC EXPERIENCE, Supportive care in cancer, 2(6), 1994, pp. 393-399
[IN-111-DTPA-D-PHE(1)]OCTREOTIDE SCINTIGRAPHY IN PATIENTS WITH CARCINOID-TUMORS - THE PREDICTIVE VALUE FOR SOMATOSTATIN ANALOG TREATMENT
Authors: JANSON ET WESTLIN JE ERIKSSON B AHLSTROM H NILSSON S OBERG K
Citation: Et. Janson et al., [IN-111-DTPA-D-PHE(1)]OCTREOTIDE SCINTIGRAPHY IN PATIENTS WITH CARCINOID-TUMORS - THE PREDICTIVE VALUE FOR SOMATOSTATIN ANALOG TREATMENT, European journal of endocrinology, 131(6), 1994, pp. 577-581
INTERFERONS ALONE OR IN COMBINATION WITH CHEMOTHERAPY OR OTHER BIOLOGICALS IN THE TREATMENT OF NEUROENDOCRINE GUT AND PANCREATIC TUMORS
Authors: OBERG K ERIKSSON B JANSON ET
Citation: K. Oberg et al., INTERFERONS ALONE OR IN COMBINATION WITH CHEMOTHERAPY OR OTHER BIOLOGICALS IN THE TREATMENT OF NEUROENDOCRINE GUT AND PANCREATIC TUMORS, Digestion, 55, 1994, pp. 64-69
SOMATOSTATIN RECEPTOR SCINTIGRAPHY - RECENT ADVANCES IMAGING ENDOCRINE PANCREATIC TUMORS
Authors: JANSON ET WESTLIN JE AHLSTROM H ERIKSSON B NILSSON S AKERSTROM G OBERG K
Citation: Et. Janson et al., SOMATOSTATIN RECEPTOR SCINTIGRAPHY - RECENT ADVANCES IMAGING ENDOCRINE PANCREATIC TUMORS, Diagnostic oncology, 3(1), 1993, pp. 45-48
SOMATOSTATIN RECEPTOR SCINTIGRAPHY OF CARCINOID-TUMORS USING THE [IN-111-DTPA-D-PHE(1)]-OCTREOTIDE
Authors: WESTLIN JE JANSON ET ARNBERG H AHLSTROM H OBERG K NILSSON S
Citation: Je. Westlin et al., SOMATOSTATIN RECEPTOR SCINTIGRAPHY OF CARCINOID-TUMORS USING THE [IN-111-DTPA-D-PHE(1)]-OCTREOTIDE, Acta oncologica, 32(7-8), 1993, pp. 783-786
LONG-TERM MANAGEMENT OF THE CARCINOID-SYNDROME - TREATMENT WITH OCTREOTIDE ALONE AND IN COMBINATION WITH ALPHA-INTERFERON
Authors: JANSON ET OBERG K
Citation: Et. Janson et K. Oberg, LONG-TERM MANAGEMENT OF THE CARCINOID-SYNDROME - TREATMENT WITH OCTREOTIDE ALONE AND IN COMBINATION WITH ALPHA-INTERFERON, Acta oncologica, 32(2), 1993, pp. 225-229
COMBINED ALPHA-INTERFERON AND GAMMA-INTERFERON THERAPY FOR MALIGNANT MIDGUT CARCINOID-TUMORS - A PHASE-I-II TRIAL
Authors: JANSON ET KAUPPINEN HL OBERG K
Citation: Et. Janson et al., COMBINED ALPHA-INTERFERON AND GAMMA-INTERFERON THERAPY FOR MALIGNANT MIDGUT CARCINOID-TUMORS - A PHASE-I-II TRIAL, Acta oncologica, 32(2), 1993, pp. 231-233
Risultati: 1-16 |